These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 23639870)

  • 21. Brivaracetam, a selective high-affinity synaptic vesicle protein 2A (SV2A) ligand with preclinical evidence of high brain permeability and fast onset of action.
    Nicolas JM; Hannestad J; Holden D; Kervyn S; Nabulsi N; Tytgat D; Huang Y; Chanteux H; Staelens L; Matagne A; Mathy FX; Mercier J; Stockis A; Carson RE; Klitgaard H
    Epilepsia; 2016 Feb; 57(2):201-9. PubMed ID: 26663401
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Levetiracetam compared to valproic acid: plasma concentration levels, adverse effects and interactions in aneurysmal subarachnoid hemorrhage.
    Mink S; Muroi C; Seule M; Bjeljac M; Keller E
    Clin Neurol Neurosurg; 2011 Oct; 113(8):644-8. PubMed ID: 21703756
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prolonged exposure to levetiracetam reveals a presynaptic effect on neurotransmission.
    Yang XF; Weisenfeld A; Rothman SM
    Epilepsia; 2007 Oct; 48(10):1861-9. PubMed ID: 17521346
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Valproic acid, but not levetiracetam, selectively decreases HDAC7 and HDAC2 expression in human ovarian cancer cells.
    Kwiecińska P; Wróbel A; Taubøll E; Gregoraszczuk EŁ
    Toxicol Lett; 2014 Jan; 224(2):225-32. PubMed ID: 24200999
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam.
    Lynch BA; Lambeng N; Nocka K; Kensel-Hammes P; Bajjalieh SM; Matagne A; Fuks B
    Proc Natl Acad Sci U S A; 2004 Jun; 101(26):9861-6. PubMed ID: 15210974
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Visualization of SV2A conformations in situ by the use of Protein Tomography.
    Lynch BA; Matagne A; Brännström A; von Euler A; Jansson M; Hauzenberger E; Söderhäll JA
    Biochem Biophys Res Commun; 2008 Oct; 375(4):491-5. PubMed ID: 18692481
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effects of sodium valproate on proliferation and apoptosis of human myelodysplastic syndromes cell line MUTZ-1].
    Chen BA; Zhao HH; Gao C; Shao ZY; Xia GH; Dohner K
    Ai Zheng; 2007 Dec; 26(12):1323-9. PubMed ID: 18076794
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chronic valproate or levetiracetam treatment does not influence cytokine levels in humans.
    Guenther S; Bauer S; Hagge M; Knake S; Olmes DG; Tackenberg B; Rosenow F; Hamer HM
    Seizure; 2014 Sep; 23(8):666-9. PubMed ID: 24880639
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The synaptic vesicle glycoprotein 2A ligand levetiracetam inhibits presynaptic Ca2+ channels through an intracellular pathway.
    Vogl C; Mochida S; Wolff C; Whalley BJ; Stephens GJ
    Mol Pharmacol; 2012 Aug; 82(2):199-208. PubMed ID: 22554805
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Up-regulated perforin expression of CD8+ blood lymphocytes in generalized non-anaphylactic drug eruptions and exacerbated psoriasis.
    Behrendt C; Gollnick H; Bonnekoh B
    Eur J Dermatol; 2000; 10(5):365-9. PubMed ID: 10882944
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Valproic acid exhibits biphasic effects on apoptotic cell death of activated lymphocytes through differential modulation of multiple signaling pathways.
    Chen Q; Ouyang DY; Geng M; Xu LH; Zhang YT; Wang FP; He XH
    J Immunotoxicol; 2011; 8(3):210-8. PubMed ID: 21457087
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Levetiracetam.
    Krishna K; Raut AL; Gohel KH; Dave P
    J Assoc Physicians India; 2011 Oct; 59():656-8. PubMed ID: 22479748
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Further evidence for a differential interaction of brivaracetam and levetiracetam with the synaptic vesicle 2A protein.
    Wood MD; Sands ZA; Vandenplas C; Gillard M
    Epilepsia; 2018 Sep; 59(9):e147-e151. PubMed ID: 30144048
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Upregulated inducible co-stimulator (ICOS) and ICOS-ligand in inclusion body myositis muscle: significance for CD8+ T cell cytotoxicity.
    Schmidt J; Rakocevic G; Raju R; Dalakas MC
    Brain; 2004 May; 127(Pt 5):1182-90. PubMed ID: 15047591
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of Ca(2+)-regulated exocytosis by levetiracetam, a ligand for SV2A, in antral mucous cells of guinea pigs.
    Harada S; Tanaka S; Takahashi Y; Matsumura H; Shimamoto C; Nakano T; Kuwabara H; Sawabe Y; Nakahari T
    Eur J Pharmacol; 2013 Dec; 721(1-3):185-92. PubMed ID: 24076180
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Levetiracetam has an activity-dependent effect on inhibitory transmission.
    Meehan AL; Yang X; Yuan LL; Rothman SM
    Epilepsia; 2012 Mar; 53(3):469-76. PubMed ID: 22292611
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of levetiracetam on hippocampal protein expression and cell proliferation in rats.
    Paulson L; Persson A; Vonck K; Van Dycke A; Kuhn HG; Boon P; Ben-Menachem E; Raedt R
    Epilepsy Res; 2010 Jun; 90(1-2):110-20. PubMed ID: 20435441
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cortico-hippocampal hyperexcitability in synapsin I/II/III knockout mice: age-dependency and response to the antiepileptic drug levetiracetam.
    Boido D; Farisello P; Cesca F; Ferrea E; Valtorta F; Benfenati F; Baldelli P
    Neuroscience; 2010 Nov; 171(1):268-83. PubMed ID: 20804820
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interaction of Approved Drugs with Synaptic Vesicle Protein 2A.
    Danish A; Namasivayam V; Schiedel AC; Müller CE
    Arch Pharm (Weinheim); 2017 Apr; 350(3-4):. PubMed ID: 28220535
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Levetiracetam resistance: Synaptic signatures & corresponding promoter SNPs in epileptic hippocampi.
    Grimminger T; Pernhorst K; Surges R; Niehusmann P; Priebe L; von Lehe M; Hoffmann P; Cichon S; Schoch S; Becker AJ
    Neurobiol Dis; 2013 Dec; 60():115-25. PubMed ID: 24018139
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.